12:00 AM
 | 
Apr 22, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Genzyme General

(GENZ), Cambridge, Mass.

Business: Biopharmaceuticals

Merrill Lynch analyst Eric Hecht decreased his 2002 EPS estimate to $1.39 from...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >